Clinical Decision Support Systems Market Size, Share & Trends Analysis Report By Product (Standalone CDSS, Integrated EHR With CDSS), By Application (Drug-Drug Interactions), By Delivery Mode, By Component, By Region, And Segment Forecasts, 2024 - 2030

Market Size & Trends

The global clinical decision support systems market size was estimated at USD 5.30 billion in 2023 and is projected to grow at a CAGR of 10.79% from 2024 to 2030. Clinical decision support systems (CDSSs) have experienced significant advancement in recent decades, providing clinicians with vital tools to make informed decisions in patient care. These systems have emerged as a promising means to improve patient outcomes and reduce overall healthcare costs.

AI and ML technologies are transforming the CDSS market, offering advanced functionalities such as predictive analytics, pattern recognition, and tailored recommendations. AI-driven CDSSs can analyze extensive datasets, detect patterns, anticipate outcomes, and suggest optimal treatment strategies. Researchers are integrating AI with CDSS, as demonstrated by the University of Texas at Austin’s Dell Medical School researchers who developed an AI-based CDSS to aid clinicians in discussing nutrition and making decisions with patients about diet improvements in December 2022.

The adoption of personalized medicine is increasing, with CDSSs playing a crucial role. These systems analyze patient data, including genetic profiles and medical histories, to customize treatment plans for individuals. By providing tailored recommendations, CDSSs enhance treatment effectiveness and reduce the risk of adverse reactions, driving market growth.

Governments worldwide are implementing regulations and incentives to promote CDSS and other healthcare IT solutions. These regulations focus on enhancing patient safety, interoperability, and care quality, prompting healthcare organizations to invest in CDSS to comply with regulatory requirements and qualify for incentives.

The COVID-19 pandemic has also positively impacted the market growth, leading to increased adoption of CDSS. CDSSs have been instrumental in supporting patient resources and services, as demonstrated by their role in real-time clinical diagnosis of COVID-19 and patient triage. Various countries offering online services have further fueled market growth. Market players have introduced CDSSs for managing COVID-19 data and insights. For instance, in May 2022, Epocrates launched an innovative tool for long COVID-19, integrating the latest updates to expand the collection of clinical decision support guidelines. Consequently, the increased adoption and introduction of clinical decision support systems have propelled market growth during the pandemic.

Case Study: CDSS for Enhanced Cancer Screening at King Faisal Hospital & Research Center

Issue:

• High rates of advanced-stage cancer due to inadequate early, preemptive, and preventative screening and detection methods.

Design & Implementation:

• Identify evidence-based guidelines compliant with government regulations for preventive care.

• Develop a strategy to integrate preventive care workflows into the EMR system.

Goals:

• Identify evidence-based preventive care measures tailored to gender, age, documented results, and chronic conditions.

• Leverage the hospital's EMR to enhance patient care.

• Provide proactive health management services to patient

Result:

• Streamlined enterprise-wide preventive care and chronic disease screening processes.

• Utilization of captured data for research, reporting, and publications.

Market Concentration & Characteristics

Innovation within the market is high, incorporating advanced technologies like AI and ML. Regular feature updates further optimize operations. 

Market players execute various strategies to support revenue and foster global market growth. These strategies include mergers & acquisitions, partnerships, and product launches aimed at bolstering their product portfolio, ultimately driving market expansion. For example, in October 2022, Beckman Coulter Diagnostics acquired StoCastic, LLC, and a provider of evidence-based decision support for hospital emergency departments (ED), strengthening Beckman Coulter Diagnostics' CDSS offerings.

Regulatory bodies like the FDA oversee the CDSS industry. In September 2022, the U.S. FDA issued finalized and revised guidance documents, such as Final CDS Guidance, addressing clinical decision support software and various digital health topics.

Key players prioritize geographic expansion to tap into new CDSS markets. Expansion often involves establishing manufacturing facilities or R&D centers in new locations or acquiring companies in different countries.

Product Insights

The standalone CDSS segment held the market with the largest revenue share of over 30.0% in 2023, because it is widely adopted for its low cost and simplicity. They don't require standardization or extensive clinical expertise and can operate without real patient data. Their user-friendly nature contributes to dominance in hospitals and clinical settings.

The integrated EHR with CDSS segment is expected to grow at the fastest CAGR during the forecast period, driven by increasing EHR adoption in multi-specialty healthcare facilities. Integrated systems provide CDSSs access to patient databases and medical histories, automating clinical workflows. In April 2023, the U.S. government proposed a rule granting providers more comprehensive access to information within their EHR systems to evaluate CDSS algorithms and outcomes. Integration of CDSSs with EHRs standardizes workflows and leverages existing datasets. In addition, more CDSS functions are built into EHR systems, supporting segment growth.

Delivery Mode Insights

Based on delivery mode, the on premise segment led the market with the largest revenue share of 42.35% in 2023. On-premise CDSS solutions offer flexibility for customization and integration with existing healthcare systems and workflows, catering to specific organizational needs. Multispecialty hospitals and large healthcare organizations prefer this system for greater data control within their infrastructure. Integration with existing systems like EHRs enables smoother data flow and interoperability, enhancing decision support efficiency.

The cloud-based segment is expected to grow at the fastest CAGR over the forecast period. Representing a significant IT advancement, they offer reliability and cost-effectiveness. Enhanced accessibility via mobile platforms and robust data protection mechanisms drive their adoption. Unlike web-based systems, cloud solutions are not dependent on web browsers, enhancing security and usability.

Application Insights

Based on application, the drug allergy alerts segment held the market with the largest revenue share of over 25.0% in 2023, because it is widely utilized in clinical decision support systems (CDSSs) to enhance patient safety and prevent adverse drug reactions (ADRs). CDSSs allow customization of alerts based on individual patient profiles and specific allergy information. Healthcare providers can tailor alert thresholds and preferences to ensure relevance and actionability for each patient. The rising burden of drug allergies is driving CDSS adoption, fueling segment growth. For example, approximately 10% of the U.S. population is allergic to penicillin, according to the CDC.

The clinical guidelines segment is expected to grow at the fastest CAGR during the forecast period. Clinical Decision Support (CDS) systems provide guidelines for diagnosis and treatment, delivering essential real-time information primarily at the point of care. These systems automate routine tasks, alert clinical teams to potential issues, and provide recommendations for assessing healthcare professionals and patients. For instance, the American Medical Informatics Association (AMIA) defines Clinical Decision Support as a mechanism to enhance health-related decision-making and actions, empowering clinicians, patients, and stakeholders to refine clinical decision-making processes and improve healthcare service quality and patient outcomes.

Component Insights

Based on component, the services segment led the market with the largest revenue share of 42.49% in 2023, offering implementation, training, support, customization, and consulting services to help healthcare organizations maximize CDSS software value and optimize clinical decision-making. This segment dominated the market as continuous technical support ensures CDSS functionality and performance. In addition, healthcare professionals require training to effectively utilize CDSS, further propelling segment growth.

The software segment is expected to grow at the fastest CAGR during the forecast period. Integrated with CPOE and EHR software, CDSS software provides enhanced decision support with customized results for individual patients. Innovations in technical support, software interoperability, and efficient outcomes are anticipated to drive market growth. For example, Elsevier Health unveiled ClinicalKey AI in February 2024, the United States' premier clinical decision support tool integrating up-to-date medical content with generative artificial intelligence (AI) to assist clinicians directly at the point of care.

Regional Insights

The clinical decision support systems market in North America accounted for the revenue share of 43.76% in 2023. This dominance is fueled by the rising demand for IT solutions in healthcare and the emphasis on delivering quality healthcare services. Rapid technological advancements further drive market growth. Initiatives promoting CDSS adoption, like EBSCO Information Services' Dyna Innovation Center launch in December 2023, contribute to regional market expansion.

U.S. Clinical Decision Support Systems Market Trends

The clinical decision support systems market in U.S. led the North America market. The surge is attributed to hospitals and healthcare institutes' increased adoption of electronic health records (EHRs). According to the Office of the National Coordinator for Health Information Technology, about 78% of physicians and 96% of hospitals in 2021 utilized certified EHR systems.

Europe Clinical Decision Support Systems Market Trends

The clinical decision support systems market in Europe is poised to maintain a significant share throughout the forecast period. This growth is fueled by the involvement of key market players, increasing acceptance of CDSS, and the establishment of supportive frameworks. For instance, in February 2024, the European Commission issued a document aimed at promoting the utilization of clinical decision-support tools.

The UK clinical decision support systems market growth is attributed to the rising adoption of advanced healthcare IT solutions. Effective collaboration between the healthcare and IT sectors, along with government initiatives, facilitates this trend. For example, in June 2023, the UK government announced plans to allocate approximately USD 22.7 million for the implementation of AI-driven decision support tools for early detection of strokes, cancers, and heart conditions.

Asia Pacific Clinical Decision Support Systems Market Trends

The clinical decision support systems market in Asia Pacific is expected to grow at the fastest CAGR during the forecast period. Collaborations among healthcare organizations, technology firms, and research institutions are facilitating the development and adoption of CDSS in the region. In addition, technological advancements, growing healthcare demands, government backing, and increased awareness of the benefits of CDSS are driving market growth.

The Australia clinical decision support systems market is primarily driven by the increasing acceptance and promotion of CDSS, particularly by governmental bodies. For instance, in April 2022, Northern Territory (NT) Health partnered with Alcidion to gain access to the advanced Miya Precision CDS platform. NT Health plans to deploy the CDS platform across its five public hospitals, remote, and community health centers, serving over 200,000 individuals. This implementation is expected to enhance the network's management of bed allocation and patient flow across NT hospitals and satellite centers.

The clinical decision support systems market in China is projected to grow at a significant CAGR during the forecast period. The Chinese government actively promotes the adoption of healthcare IT solutions, including CDSS, as part of its healthcare reform efforts. Moreover, various business initiatives undertaken by market players contribute to market expansion. For example, in June 2023, AffaMed Therapeutics unveiled the Headache CDSS in collaboration with the International Headache Center of the Chinese PLA General Hospital during the 16th Annual Meeting of Neurologists of the Chinese Medical Association.

Key Clinical Decision Support Systems Company Insights

The global market is fairly competitive. These players are involved in new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other.

Recent Developments

• In October 2023, Wolters Kluwer Health launched AI Labs, a collective resource to integrate generative AI with UpToDate, its CDS solution, enabling medical professionals to make better-informed decisions

• In August 2023, GE HealthCare launched CardioVisio for Atrial Fibrillation, a patient-centric, digital CDS tool to allow precision care

• In February 2023, EBSCO Information Services launched new features in DynaMedex Mobile App to improve clinical decision support. These enhancements improve the mobile experience for users by enabling clinicians to deliver evidence-based patient care efficiently

• Moreover, in May 2020, DHIndia announced a partnership with EHRC@IIITB & Healthelife to develop a CDSS for the screening of COVID-19. The partnership also included the formation of a minimal triage application for front-line doctors

• In March 2020, IBM Watson Health partnered with EBSCO Information Services to enhance CDSS and operations for healthcare systems and providers

Clinical Decision Support Systems Market Report Scope

Global Clinical Decision Support Systems Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the clinical decision support systems market report based on product, application, delivery mode, component, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Standalone CDSS

  • Integrated CPOE with CDSS

  • Integrated EHR with CDSS

  • Integrated CDSS with CPOE & EHR

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Drug-drug interactions

  • Drug allergy alerts

  • Clinical reminders

  • Clinical guidelines

  • Drug dosing support

  • Others

• Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

  • Web-based Systems

  • Cloud-based Systems

  • On -premise Systems

• Component Outlook (Revenue, USD Million, 2018 - 2030)

  • Hardware

  • Software

  • Services

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • Italy

    • Spain

    • France

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • China

    • India

    • Japan

    • Thailand

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait